10:05am ET
Investing
Major Blue Chip Analyst Upgrades and Downgrades in Apple, Intel, Caterpillar, Gilead, JPMorgan and Nike
These are the top 24/7 Wall St. blue chip upgrades, downgrades and initiations tracked for the week of September 9.
Companies
/Healthcare
Gilead Sciences Inc
$148.09
▼ $0.68 (−0.46%) today
Markets closed · 10:03pm ET
GILD Coverage
Page 26
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Devon Energy, Gilead, Mondelez, Urban Outfitters and More
The top analyst upgrades, downgrades and initiations seen on Tuesday morning include Biogen, Broadcom, Devon Energy, Gilead Sciences, Mondelez and Urban Outfitters.
4:04pm ET
Investing
Bristol-Myers, Verifone Dive into Friday’s 52-Week Low Club
September 2, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in Friday’s session. NYSE advancers led decliners by nearly 4 to 1 and…
4:04pm ET
Investing
Oil Drillers Noble and Ensco Join Gilead in Thursday’s 52-Week Low Club
September 1, 2016: Here are four stocks trading with relatively heavy volume among 39 equities making new 52-week lows in Thursday’s session. NYSE decliners led advancers by about 5 to 4 and…
4:04pm ET
Investing
Gilead Sciences, G-III Top Wednesday’s 52-Week Low Club
August 31, 2016: Here are four stocks trading with relatively heavy volume among 27 equities making new 52-week lows in Wednesday’s session. NYSE decliners led advancers by 3 to 2 and Nasdaq…
8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Abercrombie, Alibaba, Baidu, First Data, Marvell Technology, Under Armour and More
The top analyst upgrades, downgrades and initiations seen on Wednesday morning include Abercrombie & Fitch, Alibaba, Baidu, First Data, Marvell Technology and Under Armour.
4:04pm ET
Investing
Gilead, Ceasars in Monday’s 52-Week Low Club
August 29, 2016: Here are four stocks trading with relatively heavy volume among 21 equities making new 52-week lows in Monday’s session. NYSE advancers led decliners by about 7 to 3 and…
8:40am ET
Health and Healthcare
Short Sellers Increase Bets in Major Biotechs
The August 15 short interest data have been compared with the previous report, and short interest moves were mixed across these selected biotech stocks.
12:50pm ET
Health and Healthcare
How Much Medivation Can Really Fetch in a Buyout
Medivation has been among the top future biotech mergers for quite some time. The problem is that we still have no idea which company will buy Medivation, nor do we know what…
8:20am ET
Health and Healthcare
Why Jefferies Sees 3 Big Biotechs Having Key Upside Catalysts Coming
Investors are now focusing on fundamentals and near-term catalysts that could provide a tailwind for some of the biotech leaders.
8:50am ET
Health and Healthcare
Short Sellers Run for Cover From Major Biotechs
The short interest data are out for the July 29 settlement date and short interest decreased across these selected biotech stocks.
9:25am ET
Health and Healthcare
RBC Says Buy Big Biotechs Now for Possible Big 2016 Gains
Finally, concerns about biotech seem to be waning. An RBC research report notes that at the recent political conventions there was little to no mention of drug pricing.
10:25am ET
Health and Healthcare
How Analysts Changed Tune on Gilead After Earnings
Gilead Sciences reported its earnings on Monday of last week, and since that time there has been much analyst activity around the stock.
Chris Lange 11:05am ET
Health and Healthcare
Why Key Analyst Sees More Headwinds for Gilead Sciences
The recent performance from Gilead Sciences has analysts and investors concerned about the future. Argus believes that the headwinds are blowing harder than the tailwinds for the company.
Chris Lange 8:55am ET
Investing
Top Analyst Upgrades and Downgrades: Alphabet, Amazon, Dow Chemical, Ford, Gilead, Harley-Davidson, Western Digital and More
The top analyst upgrades, downgrades and initiations seen on Friday morning include Alphabet, Amazon, Dow Chemical, Ford, Gilead, Harley-Davidson and Western Digital.